Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
2 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
3 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
4 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
5 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
6 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
7 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
8 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
9 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
10 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
11 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
12 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
13 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
14 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
15 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
16 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
17 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
18 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
19 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
20 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
21 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
22 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
23 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
24 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
25 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
26 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
27 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
28 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
29 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
30 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
31 Endocytosis 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
32 Endocytosis 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
33 Endocytosis 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
34 Endocytosis 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
35 Endocytosis 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
36 Endocytosis 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
37 Endocytosis 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
38 Endocytosis 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
39 Endocytosis 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
40 Endocytosis 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
41 Focal adhesion 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
42 Focal adhesion 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
43 Focal adhesion 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
44 Focal adhesion 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
45 Focal adhesion 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
46 Focal adhesion 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
47 Focal adhesion 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
48 Focal adhesion 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
49 Focal adhesion 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
50 Focal adhesion 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
51 Gap junction 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
52 Gap junction 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
53 Gap junction 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
54 Gap junction 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
55 Gap junction 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
56 Gap junction 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
57 Gap junction 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
58 Gap junction 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
59 Gap junction 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
60 Gap junction 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
61 Glioma 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
62 Glioma 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
63 Glioma 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
64 Glioma 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
65 Glioma 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
66 Glioma 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
67 Glioma 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
68 Glioma 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
69 Glioma 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
70 Glioma 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
71 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
72 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
73 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
74 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
75 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
76 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
77 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
78 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
79 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
80 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
81 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
82 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
83 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
84 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
85 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
86 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
87 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
88 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
89 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
90 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
91 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
92 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
93 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
94 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
95 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
96 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
97 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
98 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
99 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
100 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
101 Melanoma 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
102 Melanoma 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
103 Melanoma 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
104 Melanoma 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
105 Melanoma 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
106 Melanoma 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
107 Melanoma 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
108 Melanoma 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
109 Melanoma 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
110 Melanoma 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
111 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
112 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
113 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
114 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
115 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
116 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
117 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
118 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
119 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
120 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
121 Pathways in cancer 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
122 Pathways in cancer 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
123 Pathways in cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
124 Pathways in cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
125 Pathways in cancer 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
126 Pathways in cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
127 Pathways in cancer 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
128 Pathways in cancer 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
129 Pathways in cancer 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
130 Pathways in cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
131 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
132 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
133 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
134 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
135 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
136 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
137 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
138 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
139 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
140 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
141 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
142 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
143 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
144 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
145 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
146 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
147 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
148 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
149 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
150 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
151 Prostate cancer 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
152 Prostate cancer 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
153 Prostate cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
154 Prostate cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
155 Prostate cancer 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
156 Prostate cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
157 Prostate cancer 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
158 Prostate cancer 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
159 Prostate cancer 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
160 Prostate cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
161 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
162 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
163 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
164 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
165 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
166 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
167 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
168 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
169 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
170 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
171 Ras signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
172 Ras signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
173 Ras signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
174 Ras signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
175 Ras signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
176 Ras signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
177 Ras signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
178 Ras signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
179 Ras signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
180 Ras signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
181 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
182 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
183 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
184 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
185 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
186 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
187 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
188 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
189 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
190 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬

Back to top